POLARIS GROUP has a total of 57 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 2001. It filed its patents most often in United States, EPO (European Patent Office) and Taiwan. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are SYNTHETIC BIOLOG INC, ORGENESIS INC and NOVO NORDISK KHELS KEA AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | Taiwan | 6 | |
#4 | Canada | 5 | |
#5 | China | 5 | |
#6 | WIPO (World Intellectual Property Organization) | 5 | |
#7 | Hong Kong | 4 | |
#8 | Australia | 3 | |
#9 | Brazil | 3 | |
#10 | Japan | 3 | |
#11 | Republic of Korea | 3 | |
#12 | Singapore | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Organic fine chemistry | |
#5 | Environmental technology | |
#6 | Measurement | |
#7 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Wu Bor-Wen | 23 |
#2 | Thomson James A | 20 |
#3 | Almassy Robert | 15 |
#4 | Sisson Wes | 15 |
#5 | Shia Wei-Jong | 13 |
#6 | Chen Li-Chang | 13 |
#7 | Nie Zhe | 11 |
#8 | Erickson Philip Eugene | 11 |
#9 | Chu Shaosong | 11 |
#10 | Perretta Carin L | 11 |
Publication | Filing date | Title |
---|---|---|
CN110121340A | The composite of PEGylated arginine deiminase | |
US2018010114A1 | Combination cancer immunotherapies with arginine depletion agents | |
TW201735943A | Methods of treatment with arginine deiminase | |
US2008070893A1 | Protein kinase inhibitors | |
AU2003282883A1 | Methods for inhibiting viral replication in vivo |